BSE .
Godavari Drugs Ltd's board to meet on Feb 11, 2026, to approve unaudited financial results for Q3 and nine months ending Dec 31, 2025.
Trading window for designated persons closed from Jan 1, 2026, to 48 hours post financial results declaration.